Calpain is an intracellular Ca2+ -activated protease that is involved in numerous Ca2+ dependent regulation of protein function in many cell types. This paper tests a hypothesis that calpains are involved in Ca2+ -dependent increase of the late sodium current (INaL) in failing heart. Chronic heart failure (HF) was induced in 2 dogs by multiple coronary artery embolization. Using a conventional patch-clamp technique, the whole-cell INaL was recorded in enzymatically isolated ventricular cardiomyocytes (VCMs) in which INaL was activated by the presence of a higher (1μM) intracellular [Ca2+] in the patch pipette. Cell suspensions were exposed to a cell- permeant calpain inhibitor MDL-28170 for 1–2 h before INaL recordings. The numerical excitation-contraction coupling (ECC) model was used to evaluate electrophysiological effects of calpain inhibition in silico. MDL caused acceleration of INaL decay evaluated by the two-exponential fit (τ1 = 42±3.0 ms τ2 = 435±27 ms, n = 6, in MDL vs. τ1 = 52±2.1 ms τ2 = 605±26 control no vehicle, n = 11, and vs. τ1 = 52±2.8 ms τ2 = 583±37 ms n = 7, control with vehicle, P<0.05 ANOVA). MDL significantly reduced INaL density recorded at –30 mV (0.488±0.03, n = 12, in control no vehicle, 0.4502±0.0210, n = 9 in vehicle vs. 0.166±0.05pA/pF, n = 5, in MDL). Our measurements of current-voltage relationships demonstrated that the INaL density was decreased by MDL in a wide range of potentials, including that for the action potential plateau. At the same time the membrane potential dependency of the steady-state activation and inactivation remained unchanged in the MDL-treated VCMs. Our ECC model predicted that calpain inhibition greatly improves myocyte function by reducing the action potential duration and intracellular diastolic Ca2+ accumulation in the pulse train. Conclusions Calpain inhibition reverses INaL changes in failing dog ventricular cardiomyocytes in the presence of high intracellular Ca2+. Specifically it decreases INaL density and accelerates INaL kinetics resulting in improvement of myocyte electrical response and Ca2+ handling as predicted by our in silico simulations.
References
[1]
Maltsev VA, Undrovinas A (2008) Late sodium current in failing heart: Friend or foe? Progr Biohys Molec Biol 96: 421–451.
[2]
Noble D, Noble PJ (2006) Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload. Heart 92: iv1–iv5.
[3]
Undrovinas AI, Belardinelli L, Undrovinas NA, Sabbah HN (2006) Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current. J Cardiovasc Electrophysiol 17: S169–S177.
[4]
Antzelevitch C, Belardinelli L, Zygmunt AC, Burashnikov A, Di Diego JM, et al.. (2004) Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation 110: 904–910. Epub 2004 Aug 2009.
[5]
Scirica BM, Morrow DA, Hod H, Murphy SA, Belardinelli L, et al. (2007) Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial. Circulation 116: 1647–1652.
[6]
Maltsev VA, Reznikov V, Undrovinas NA, Sabbah HN, Undrovinas A (2008) Modulation of the late sodium current by Ca2+, calmodulin, and CaMKI I in normal and failing dog cardiomyocytes: similarities and differences. Am J Physiol Heart Circ Physiol 294: H1597–H1608.
[7]
Wagner S, Dybkova N, Rasenack EC, Jacobshagen C, Fabritz L, et al. (2006) Ca/calmodulin-dependent protein kinase II regulates cardiac Na channels. J Clin Invest 22: 22.
[8]
Chauhan VS, Tuvia S, Buhusi M, Bennett V, Grant AO (2000) Abnormal cardiac Na+ channel properties and QT heart rate adaptation in neonatal ankyrin(B) knockout mice. Circ Res 86: 441–447.
[9]
Mohler PJ, Schott JJ, Gramolini AO, Dilly KW, Guatimosim S, et al. (2003) Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421: 634–639.
[10]
Mishra S, Undrovinas NA, Maltsev VA, Reznikov V, Sabbah HN, et al. (2011) Post-transcriptional silencing of SCN1B and SCN2B genes modulates late sodium current in cardiac myocytes from normal dogs and dogs with chronic heart failure. Am J Physiol Heart Circ Physiol 301: H1596–1605.
[11]
Bukowska A, Lendeckel U, Bode-Boger SM, Goette A (2010) Physiologic and Pathophysiologic Role of Calpain: Implications for the Occurrence of Atrial Fibrillation. Cardiovasc Ther: 1755–5922.
[12]
Patterson C, Portbury AL, Schisler JC, Willis MS (2011) Tear me down: role of calpain in the development of cardiac ventricular hypertrophy. Circ 109: 453–462.
[13]
Hein S, Kostin S, Heling A, Maeno Y, Schaper J (2000) The role of the cytoskeleton in heart failure. Cardiovasc Res 45: 273–278.
[14]
Heling A, Zimmermann R, Kostin S, Maeno Y, Hein S, et al. (2000) Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. Circ Res 86: 846–853.
[15]
Matsumura Y, Saeki E, Otsu K, Morita T, Takeda H, et al. (2001) Intracellular calcium level required for calpain activation in a single myocardial cell. J Mol Cell Cardiol 33: 1133–1142.
[16]
Tsuji T, Ohga Y, Yoshikawa Y, Sakata S, Abe T, et al. (2001) Rat cardiac contractile dysfunction induced by Ca2+ overload: possible link to the proteolysis of alpha-fodrin. Am J Physiol Heart Circ Physiol 281: H1286–1294.
[17]
Undrovinas NA, Maltsev VA, Belardinelli L, Sabbah HN, Undrovinas A (2010) Late sodium current contributes to diastolic cell Ca2+ accumulation in chronic heart failure. J Physiol Sci 60: 245.
[18]
Sabbah HN, Goldberg AD, Schoels W, Kono T, Webb C, et al. (1992) Spontaneous and inducible ventricular arrhythmias in a canine model of chronic heart failure: relation to haemodynamics and sympathoadrenergic activation. Eur Heart J 13: 1562–1572.
[19]
Sabbah HN, Stein PD, Kono T, Gheorghiade M, Levine TB, et al. (1991) A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol 260: H1379–1384.
[20]
Maltsev VA, Sabbah HN, Higgins RSD, Silverman N, Lesch M, et al. (1998) Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes. Circulation 98: 2545–2552.
[21]
Urthaler F, Wolkowicz PE, Digerness SB, Harris KD, Walker AA (1997) MDL-28170, a membrane-permeant calpain inhibitor, attenuates stunning and PKC epsilon proteolysis in reperfused ferret hearts. Cardiovasc Res 35: 60–67.
[22]
Kameyama M, Hofmann F, Trautwein W (1985) On the mechanism of beta-adrenergic regulation of the Ca channel in the guinea-pig heart. Pflugers Arch 405: 285–293.
[23]
Mathias RT, Cohen IS, Oliva C (1990) Limitations of the whole cell patch clamp technique in the control of intracellular concentrations. Biophys J 58: 759–770.
[24]
Oliva C, Cohen IS, Mathias RT (1988) Calculation of time constants for intracellular diffusion in whole cell patch clamp configuration. Biophys J 54: 791–799.
[25]
Pusch M, Neher E (1988) Rates of diffusional exchange between small cells and a measuring patch pipette. Pflugers Arch 411: 204–211.
[26]
Undrovinas A, Maltsev VA (2008) Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart. Cardiovasc Hematol Agents Med Chem 6: 348–359.
[27]
Maltsev VA, Sabbah HN, Undrovinas AI (2002) Down-regulation of sodium current in chronic heart failure: effects of long-term therapy with carvedilol. Cell Mol Life Sci 59: 1561–1568.
[28]
Winslow RL, Rice J, Jafri S, Marban E, O'Rourke B (1999) Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, II: model studies. Circ Res 84: 571–586.
[29]
Maltsev VA, Undrovinas AI (2006) A multi-modal composition of the late Na+ current in human ventricular cardiomyocytes. Cardiovasc Res 69: 116–127.
[30]
Maltsev VA, Silverman N, Sabbah HN, Undrovinas AI (2007) Chronic heart failure slows late sodium current in human and canine ventricular myocytes: Implications for repolarization variability. Eur J Heart Fail 9: 219–227.
[31]
Hanna RA, Campbell RL, Davies PL (2008) Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin. Nature 456: 409–412.
[32]
Carragher NO (2006) Calpain inhibition: a therapeutic strategy targeting multiple disease states. Curr Pharm Des 12: 615–638.
[33]
Belles B, Malecot CO, Hescheler J, Trautwein W (1988) “Run-down” of the Ca current during long whole-cell recordings in guinea pig heart cells: role of phosphorylation and intracellular calcium. Pflugers Arch 411: 353–360.
[34]
Belles B, Hescheler J, Trautwein W, Blomgren K, Karlsson JO (1988) A possible physiological role of the Ca-dependent protease calpain and its inhibitor calpastatin on the Ca current in guinea pig myocytes. Pflugers Arch 412: 554–556.
[35]
Yoshida K, Inui M, Harada K, Saido TC, Sorimachi Y, et al. (1995) Reperfusion of rat heart after brief ischemia induces proteolysis of calspectin (nonerythroid spectrin or fodrin) by calpain. Circ Res 77: 603–610.
[36]
Wingo TL, Shah VN, Anderson ME, Lybrand TP, Chazin WJ, et al. (2004) An EF-hand in the sodium channel couples intracellular calcium to cardiac excitability. Nat Struct Mol Biol 11: 219–225.
[37]
Abriel H, Kass RS (2005) Regulation of the voltage-gated cardiac sodium channel Nav1.5 by interacting proteins. Trends Cardiovasc Med 15: 35–40.
[38]
Malhotra JD, Kazen-Gillespie K, Hortsch M, Isom LL (2000) Sodium channel β subunits mediate homophilic cell adhesion and recruit ankyrin to points of cell-cell contact. J Biol Chem 275: 11383–11388.
[39]
January CT, Moscucci A (1992) Cellular mechanisms of early afterdepolarizations. Annals of the New York Academy of Sciences 644: 23–32.
[40]
Sossalla S, Wagner S, Rasenack EC, Ruff H, Weber SL, et al. (2008) Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts – Role of late sodium current and intracellular ion accumulation. J Mol Cell Cardiol 14: 14.
